Word

Status

Pending

Status Code

681

Status Date

Wednesday, March 20, 2024

Serial Number

79375034

Mark Type

2000

Filing Date

Thursday, June 8, 2023

Published for Opposition

Tuesday, April 23, 2024

Trademark Owner History

KOWA COMPANY, LTD.

Classifications

5 Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of diseases of the circulatory system and diabetes-related diseases, pharmaceutical preparations for treatment of fatty liver and steatohepatitis, pharmaceutical preparations for the treatment of cardiovascular disorders and metabolic disorders, pharmaceutical preparations for the treatment of digestive system disease, pharmaceutical preparations for the treatment of primary biliary cirrhosis, pharmaceutical preparations for the treatment of fatty liver and liver hepatitis and liver cirrhosis, pharmaceutical preparations for the treatment of liver disease, pharmaceutical preparations for the treatment of metabolic disease, pharmaceutical preparations for the prevention and treatment of disorders of the metabolic system, analgesics; pharmaceutical and biological preparations for the treatment of diseases of the central nervous system, peripheral nervous system, sensory organs, the circulatory system, respiratory system, and the digestive system; pharmaceutical substances for the treatment of dermatological diseases, allergies and urogenital or anal conditions; veterinary preparations, namely, veterinary preparations for the treatment of diseases of the circulatory system and diabetes-related diseases, veterinary preparations for treatment of fatty liver and steatohepatitis, veterinary preparations for the treatment of cardiovascular disorders and metabolic disorders, veterinary preparations for the treatment of digestive system disease, veterinary preparations for the treatment of primary biliary cirrhosis, veterinary preparations for the treatment of fatty liver and liver hepatitis and liver cirrhosis, veterinary preparations for the treatment of liver disease, veterinary preparations for the treatment of metabolic disease, veterinary preparations for the prevention and treatment of disorders of the metabolic system, analgesics; veterinary pharmaceutical and biological preparations for the treatment of diseases of the central nervous system, peripheral nervous system, sensory organs, the circulatory system, respiratory system, and the digestive system; veterinary pharmaceutical substances for the treatment of dermatological diseases, allergies and urogenital or anal conditions; sanitary preparations for medical use; anti-inflammatory agents, namely, topical preparations in the form of gels and salves, adhesive skin patches, liquid formulations, cream and sprays, all for relieving pain

The mark consists of two incomplete shaded rectangular shapes in green, with a puzzle like circular cut out in the center of the two rectangles; on the left rectangle is a dark blue shaded circle in the center, a light blue circle in the center of the dark blue circle and a green oval design at the center of the light blue circle; the rectangle on the left contains four white circles indicating reflecting light; the overall rectangular design appears in fading shades of green and white; the color gray appears as shadowing around the mark.
The colors green, gray, white, blue and dark blue are claimed as a feature of the mark; the mark consists of two incomplete shaded rectangular shapes in green, with a puzzle like circular cut out in the center of the two rectangles, on the left rectangle is a dark blue shaded circle in the center and a lighter blue circle in the center of the darker circle, the rectangle on the left contains four white circles indicating reflecting light, and the entire design contains a gray shadow.
The color(s) green, dark blue, light blue, white and gray is/are claimed as a feature of the mark.

Trademark Events

Apr 10, 2024

Notification Of Possible Opposition Sent To Ib

Apr 10, 2024

Notice Of Start Of Opposition Period Created, To Be Sent To Ib

Apr 3, 2024

Notification Of Notice Of Publication E-Mailed

Mar 20, 2024

Approved For Pub - Principal Register

Mar 14, 2024

Teas/Email Correspondence Entered

Mar 14, 2024

Correspondence Received In Law Office

Mar 14, 2024

Teas Response To Office Action Received

Oct 24, 2023

Refusal Processed By Ib

Sep 27, 2023

Non-Final Action Mailed - Refusal Sent To Ib

Sep 27, 2023

Refusal Processed By Mpu

Sep 12, 2023

Non-Final Action (Ib Refusal) Prepared For Review

Sep 11, 2023

Non-Final Action Written

Sep 10, 2023

Assigned To Examiner

Sep 10, 2023

Correction Transaction Received From Ib

Aug 11, 2023

Application Filing Receipt Mailed

Aug 7, 2023

New Application Office Supplied Data Entered

Aug 6, 2023

Limitation From Original Application Entered

Jul 21, 2023

Sn Assigned For Sect 66a Subseq Desig From Ib